PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...

PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...

Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.

A new study reveals that gut bacteria and metabolites may hold the key to detecting serious digestive diseases earlier and more easily. Using AI, scientists found that biomarkers linked to one ...

Head and neck cancers represent a biologically heterogeneous group of malignancies requiring accurate diagnosis, staging, and risk stratification for ...

New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.

Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, ...

DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...